Clinical trial
Caffeine for Excessive Daytime Somnolence in Parkinson's Disease
NCT00459420 is registered in ClinicalTrials.gov with Ron Postuma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Caffeine for Excessive Daytime Somnolence in Parkinson's Disease
- Lead sponsor
- Ron Postuma
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- July 31, 2011
- Enrollment
- 58 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
excessive daytime somnolence, parkinson's disease